NATURE’S SUNSHINE PRODUCTS, INC. Increase (Decrease) in Contract with Customer, Asset
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Increase (Decrease) in Contract with Customer, Asset of -$406.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2020-05-11
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-03-31 was -$406.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-09-30 was $912.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-06-30 was -$1.00M.
- NATURE’S SUNSHINE PRODUCTS, INC. increase (decrease) in contract with customer, asset for the quarter ending 2019-03-31 was -$35.00K.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month |
|---|---|---|---|
| 2020-03-31 | -$406.00K 10-Q · filed 2020-05-11 | ||
| 2019-09-30 | $912.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$92.00K derived: sum of 2 quarters · filed 2019-11-07 | -$127.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.04M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$35.00K 10-Q · filed 2020-05-11 | ||
| 2018-09-30 | -$461.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.33M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $1.79M 10-Q · filed 2019-08-09 | ||
| 2017-09-30 | $468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$1.12M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$1.59M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |